Now Virtual! The 9th Annual Meeting of the ASCCT
Monday October 19, 2020 09:00AM through Friday October 23, 2020 04:00PM
The 9th Annual ASCCT meeting will be held virtually the week of October 19th, 2020, culminating with an add-on training on the EPA Chemistry Dashboard and related tools October 23rd.
Given the continuing uncertainties related to travel and large gatherings, the organizing committee and board of directors have decided to proceed with a virtual meeting. The meeting will still feature plenary speakers, panel discussions, oral and poster presentations drawn from submitted abstracts, and opportunities for early-career scientists through a mentoring session and poster awards.
The conference theme will address the US EPA goal to eliminate reliance on mammalian tests to make regulatory decisions by 2035, and the various considerations—science and policy—related to meeting this goal.
Accepted Plenary speakers:
- Tara Barton-McLaren, Health Canada
- Richard Keigwin, US EPA
- Sue Marty, Dow Chemical
- Adrian Roth, Roche
Presentations and discussions will consider:
- Solutions and research needed for longer-term and complex endpoint replacement
- Fit for purpose validation frameworks and case studies
- Needs of the regulated and regulator community
- Benchmarking NAMs without in vivo tests
- Public communication
- Overcoming barriers related to comfort, training, and experience
- Effects on, and contributions from, pharmaceutical and other sectors
Submission deadline is July 31, 2020
The organizing committee is committed to putting on a stimulating and engaging meeting. We are exploring platforms that will allow ASCCT members and guests the opportunity to share their science and network with colleagues despite remaining at home. Because of the online format, the meeting may be spread out across three or four shorter days rather than two full days.
Perhaps this will be an opportunity to increase meeting attendance! We hope you will join us. Most of the meeting program is built from submitted abstracts, so please submit your abstracts today and help us shape the future of in vitro and in silico toxicology.